Production and certification of BOTS-1: bovine muscle–certified reference material for incurred veterinary drug residues
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-023-04794-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Garnet McRae und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Research Council Canada, Metrology, 1200 Montreal Road, ON, K1A 0R6, Ottawa, Canada. garnet.mcrae@nrc-cnrc.gc.ca. Hauptthemen laut MEDLINE: Veterinary Drugs, Drug Residues. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council Canada.
Abstract (Originalsprache)
A freeze-dried bovine muscle–certified reference material (CRM), known as BOTS-1 (DOI: https://doi.org/10.4224/crm.2018.bots-1 ), containing incurred residues of commonly used veterinary drugs was produced and certified for the mass fraction of eight veterinary drug residues. Value assignment was carried out using liquid chromatography tandem mass spectrometry (LC–MS/MS) methods in conjunction with isotope dilution and standard addition approaches involving stable isotope internal standards. Data from the National Research Council of Canada (NRC), Canadian Food Inspection Agency (CFIA), United States Department of Agriculture (USDA), and the Federal Office of Consumer Protection and Food Safety in Germany (BVL) were used for value assignment. Results for two drug residues were also obtained through an international inter-laboratory comparison CCQM-K141/P178 organized under the auspices of the International Bureau of Weights and Measures (BIPM). Quantitative NMR ( 1 H-qNMR) was used to characterize primary standards of all veterinary drugs certified. The certified mass fractions of the veterinary drug residues were 490 ± 100 µg/kg for chlorpromazine, 44 ± 4.4 µg/kg for ciprofloxacin, 3.3 ± 1.4 µg/kg for clenbuterol, 9.5 ± 0.8 µg/kg for dexamethasone, 57 ± 4.8 µg/kg for enrofloxacin, 3.0 ± 0.4 µg/kg for meloxicam, 12.4 ± 1.2 µg/kg for ractopamine, and 2290 ± 120 µg/kg for sulfadiazine with expanded uncertainties quoted (95% confidence) which include the effects due to between-bottle inhomogeneity, instability during long-term storage and transportation, and characterization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Research Council Canada, Metrology, 1200 Montreal Road, ON, K1A 0R6, Ottawa, Canada. garnet.mcrae@nrc-cnrc.gc.ca.
- National Research Council Canada, Metrology, 1200 Montreal Road, ON, K1A 0R6, Ottawa, Canada.
- Canadian Food Inspection Agency, 116 Veterinary Road, Saskatoon, SK, S7N 2R3, Canada.
- US Department of Agriculture, Agricultural Research Service, Eastern Regional Research Center, 600 East Mermaid Lane, Wyndmoor, PA, 19038, USA.
- German Federal Office of Consumer Protection and Food Safety (BVL), Mauerstrasse 39-42, 10117, Berlin, Germany.
Förderung
- National Research Council Canada
Zitieren
APA
McRae, G., Leek, D. M., Meija, J., Shurmer, B., Lehotay, S. J., Polzer, J., Melanson, J. E., & Mester, Z. (2024). Production and certification of BOTS-1: bovine muscle–certified reference material for incurred veterinary drug residues. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-023-04794-5
Vancouver
McRae G, Leek DM, Meija J, Shurmer B, Lehotay SJ, Polzer J, et al. Production and certification of BOTS-1: bovine muscle–certified reference material for incurred veterinary drug residues. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-023-04794-5
BibTeX
@article{McRae2024,
author = {McRae, Garnet and Leek, Donald M and Meija, Juris and Shurmer, Bryn and Lehotay, Steven J and Polzer, Joachim and Melanson, Jeremy E and Mester, Zoltan},
title = {Production and certification of BOTS-1: bovine muscle–certified reference material for incurred veterinary drug residues},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-023-04794-5}
}
EUVIMED